Futura Medical plc
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| FUM.L | DARE | CANF | FLNA | CELZ | VTGN | |
|---|---|---|---|---|---|---|
| Market cap | 2.79M | 13.02M | 5.06M | 27.63M | 4.95M | 8.18M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -0.3 | -1.3 | -1.8 | — | -0.7 | -0.1 |
| Price/book | 0.6 | -17.9 | 0.7 | 0.4 | 0.5 | 0.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −91.83% | −63.43% | −80.12% | −80.74% | −78.05% | −95.52% |
| Today | −0.79% | +1.83% | +3.02% | −3.75% | −3.21% | +9.70% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All FUM.L news ›Futura Medical (LSE:FUM) Draws Bid Talk Beyond the FTSE 100
The maker of Eroxon, an over-the-counter topical gel for erectile dysfunction, once also had a toe in the cannabinoid space through a CBD gel project, which gives the AIM-quoted group its place on cannabis watchlists. The company stressed…
Futura Medical (LON:FUM) Stock Falls 12.4% – Should You Sell?
Posted by Defense World Staff on Oct 18th, 2026 Shares of Futura Medical plc (LON:FUM – Get Free Report) dropped 12.4% during mid-day trading on Friday. The stock traded as low as GBX 0.18 and last traded at GBX 0.18. Approximately…
REG - Futura Medical PLC - Form 8 (DD) - Futura Medical
PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS) Rules 8.1, 8.2 and 8.4 of the Takeover Code (the “Code”) Benjamin Turner, James Pope &…
Futura Medical revises sale timetable as finance director steps down
Proactive has a commercial relationship with Futura Medical PLC. This article was produced independently under Proactive's Editorial Standards Policy. Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX), the consumer healthcare group behind…
Futura Medical Reports Higher Scores in Eroxon Intense Home Trial Ahead of 2027 Launch
Futura Medical says a new home trial of reformulated Eroxon Intense scored higher than both the original version and current Eroxon on hardness satisfaction. The shares are little changed after a formal sale process was launched in…
Galliford Try, Quantum Blockchain, Futura Medical, Helix Exploration, 88 Energy, Powerhouse Energy - Small Cap Snapshot
Proactive has a commercial relationship with Galliford Try Holdings PLC. This article was produced independently under Proactive's Editorial Standards Policy. Galliford Try Holdings PLC (LSE:GFRD) has landed a spot on the University of…
Futura Medical plans 2027 Eroxon Intense launch after positive test
Proactive has a commercial relationship with Futura Medical PLC. This article was produced independently under Proactive's Editorial Standards Policy. Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX), the consumer healthcare company behind…
Why Is Futura Medical (LSE:FUM) Filing A Stream Of Takeover Code Disclosures This Week?
Under those rules, parties with a meaningful stake in the company must publicly report dealings, which is why the AIM-listed sexual health specialist appears so often on the news wire. The company has said publicly that it launched a…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- proactiveinvestors.com3
- tradingview.com3
- asktraders.com1
- defenseworld.net1
- kalkinemedia.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.